Previous Article | Next Article 
Journal of Clinical Microbiology, June 2007, p. 1985-1988, Vol. 45, No. 6
0095-1137/07/$08.00+0 doi:10.1128/JCM.00159-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Multiplex PCR Assay for Rapid and Accurate Capsular Typing of Group B Streptococci
Claire Poyart,1,2,3*
Asmaa Tazi,1,2,3
Hélène Réglier-Poupet,1,2,3
Annick Billoët,1
Nicole Tavares,1
Josette Raymond,1 and
Patrick Trieu-Cuot2,4
Service de Bactériologie,1
Centre National de Référence des Streptocoques, Groupe Hospitalier Cochin-Saint Vincent de Paul, Assistance Publique-Hôpitaux de Paris, 27 rue du Faubourg Saint Jacques, 75679 Paris, France,2
Institut Cochin-INSERM U567-UMR CNRS 810, Faculté de Médecine Université Descartes, 22 rue Méchain, 75014 Paris, France,3
Unité de Biologie des Bactéries Pathogènes à Gram-Positif-URA CNRS 2172, Institut Pasteur, 75724 Paris, France4
Received 22 January 2007/
Returned for modification 5 March 2007/
Accepted 12 March 2007

ABSTRACT
We developed a simple, specific, and sensitive two-multiplex-PCR
assay that enabled the detection of all known group B streptococcal
(GBS) capsular polysaccharides. This test is well adapted for
GBS capsular polysaccharide typing in large-scale epidemiological
studies.

TEXT
Group B streptococci (GBS;
Streptococcus agalactiae) are a leading
cause of invasive infections in neonates and a serious cause
of mortality or morbidity in adults with underlying diseases
(
13). Nine distinct capsular polysaccharide (CPS) serotypes
have been described (
6,
7). The CPS is commonly used for strain
typing. The commercial kits most widely used are based on latex
agglutination (LA), but these tests are only moderately reliable,
resulting in nontypeability (NT) or erroneous serotyping of
the isolates. Therefore, molecular capsular typing techniques
are attractive because they are reproducible, specific, and
easy to perform. Different genotypic methods have been described
for the molecular capsular typing of GBS (
1,
2,
8,
9,
14,
17).
However, while these techniques are relatively easy to perform
in the routine laboratory, they all involve the conjunction
of two different techniques, e.g., PCR plus sequencing, PCR
plus hybridization, or PCR plus enzymatic restriction. We report
in this work on a simple multiplex PCR assay which enables the
detection of all known GBS CPSs.
The DNA sequences of the cps operons of all GBS CPSs that have been described have recently been made available (3). The nine cps DNA sequences were analyzed by using Beacon Designer 5.1 software to generate CPS-specific primer pairs, which enabled the amplification of fragments of different sizes that could be easily discriminated by agarose gel electrophoresis. Primer specificity was tested against the sequences in the GenBank database by using BLAST searches to verify the absence of serendipitous similarities. PCR simulations were carried out by using AmplifX 1.37 software. Primers that met these criteria and that were specific for sequences corresponding to CPS types Ia, Ib, II, IV,V, VI, VII, and VIII were identified; and the most appropriate pairs, which were selected on the basis of similar melting temperatures and the ability to generate distinguishable amplicon sizes, were retained (Table 1). Due to the high degree of sequence similarity of these loci, we failed to define primers specific for CPS type III. We therefore selected the pairs with the lowest potential for cross-hybridization with other cps operons. As shown in Table 1, all but one of the primer pairs were predicted to be CPS type specific, whereas the primer pair used to detect type III strains was expected to cross-react with type Ia and II strains. Moreover, the size differences between the amplicons allowed us to readily identify each CPS type, based on the electrophoretic mobility of the corresponding PCR product (Table 1).
The specificity and efficiency of each primer pair used separately
were determined by PCR with DNA extracted from 33 GBS strains
representative of all nine serotypes (
n = 5 strains each for
types Ia, Ib, II, III, IV, and V and
n = 3 strains each for
types VI, VII, and VIII). This analysis included the sequenced
strains A909 (type Ia), NEM316 (type III), and 2603 V/R (type
V) (
5,
15,
16). The expected PCR patterns were obtained with
all primer pairs and strains except primers III-F and III-R,
which did not yield the expected 1,826-bp fragment with the
five serotype II strains tested (data not shown). The specificities
of the PCRs were assessed by sequencing the PCR products derived
from the 33 strains. As expected, all sequenced amplicons displayed
>98% identity with the corresponding CPS reference sequence.
Our finding that primers III-F and III-R did not hybridize with any serotype II clinical isolates suggested that the sequence with GenBank accession number AY375362 (3) might not be representative of cps operons encoding the serotype II CPS. Sequencing of the central region of the cps operons containing the genes presumably targeted by primers III-F and III-R of two unrelated CPS type II GBS isolates (isolates CNRCCH393 and CNRCCH394) revealed that these loci were identical to that of type II strain 18RS21 (Fig. 1) (4, 15). However, comparison of the strain 18RS21 sequence and the sequence with GenBank accession number AY375362 revealed that only their 5' and 3' extremities were identical, whereas the internal segments were different in size and gene content (Fig. 1A). Based on our results and those presented in previous reports (10, 17), we propose that the strain 18RS21 sequence should be considered the cps2 sequence prototype. The 18RS21 and AY375362 sequences could be designated cps2a and cps2b, respectively. Thus, at least two different cps2 loci, cps2a and cps2b, could encode serotype II CPS.
Our aim was to develop a simple multiplex PCR assay that enables
accurate GBS CPS typing. Two primer mixes (with mix I containing
primer pairs specific for CPS types Ia, Ib, II, III, and IV
and mix II containing primer pairs specific for CPS types V,
VI, VII, and VIII) were used in separate PCRs. In every reaction,
the CPS type could be unambiguously determined, with each type
possessing a characteristic electrophoretic pattern (Fig.
2A and B).
In this assay, the systematic use of two PCR mixes per strain
provided an internal negative control, as only one mix should
produce a PCR fragment. A third PCR (with primer pair dltS-F
and dltS-R) targeting the GBS-specific
dltS gene (
11) was also
included as an internal positive control (Fig.
2C).
Four hundred twenty-six human nonredundant GBS isolates collected
in different French geographical areas between 2004 and 2006
were studied. Fifty-three (12.4%) strains were isolated from
patients with GBS invasive diseases: 47 (11%; 16 from neonates,
2 from children, and 29 from adults) were from blood cultures
and 6 (1.4%; all from neonates) were from cerebrospinal fluid.
Two hundred thirty-two strains (54%) were isolated from vaginal
samples from pregnant women, and 70 strains (16%) were from
colonized but noninfected neonates. Seventy-one additional strains
(16.6%) were obtained from urine samples (
n = 56) or pus from
various sites (
n = 15). All GBS isolates were serotyped by agglutination
with a commercial standard kit from Essum AB (Umea, Sweden)
containing immunoglobulin G binding particles coated with rabbit
antibodies specific to capsular serotypes Ia, Ib, II, III, IV,
and V. LA serotyping (LAS) allowed us to identify the capsular
serotypes of 93% (397/426) of the strains studied (Table
2).
All GBS strains were also tested by using the multiplex PCR
system illustrated in Fig.
2. Following PCR with the dltS primer
pair, all strains yielded the expected PCR product, which confirmed
that the DNA preparations were devoid of PCR inhibitors and
that the corresponding strains were GBS. A capsular genotype
was assigned to 99.7% (425/426) of the isolates (Table
2). Among
the 397 strains typeable by both methods, the results of PCR
CPS typing and LAS were in agreement for 394 isolates (99%).
The three discordant strains (LAS and PCR CPS typing results
for the three strains, III and IV, respectively; V and Ib, respectively;
and V and III, respectively; Table
2) were each retested in
three independent LAS experiments, and the PCR products were
checked by sequencing. The same discordances between the phenotypic
and the genotypic assays were obtained. The CPS types of these
three strains determined by PCR were considered to be correct,
based on the assumption that genotypic methods are more reliable
than phenotypic methods.
Among the 29 (7%) NT strains that did not react or that gave
weak polyagglutination by LAS, 22 (5.1%) were assigned by PCR
to type Ia (
n = 16), Ib (
n = 1), II (
n = 2), IV (
n = 1), and
V (
n = 2). Six strains (1.4%) were assigned by PCR to type VI
(
n = 1) and type VII (
n = 5) and were classified as NT by LAS
due to the absence of the corresponding antisera in our kit.
A single strain, CNRCCH265, could not be typed by either LAS
or the PCR assay and was further studied. We searched by PCR
for the presence of genes
cpsA to -
E;
cpsL; and
neuB, -
A, -
C,
and -
D, which are conserved in all nine GBS
cps operons (
3).
This analysis indicated that the genes
cpsC to -
E and
cpsL were
apparently missing from this strain (data not shown). Sequence
analysis revealed that a single large deletion that resulted
in an out-of-frame fusion between the first half of
cpsC and
the second half of
cpsM occurred in strain CNRCCH265 (Fig.
1B).
The loss of the genes
cpsC to -
M is consistent with its NT phenotype.
GBS isolates that are NT due to the presence of mutations or
insertion sequences in the
cps biosynthetic genes have been
described (
2,
3,
8,
9,
12,
14,
17). However, we describe here
the first molecular characterization of a GBS clinical isolate
bearing a large deletion within the
cps operon.
In conclusion, the multiplex PCR assay described in this work provides a simple tool for GBS CPS typing. This sensitive and specific method enables the characterization of all known GBS CPSs, thereby reducing the rate of detection of NT isolates. This assay is therefore particularly well adapted for GBS CPS typing in large-scale epidemiological studies.
Nucleotide sequence accession numbers.
The GenBank/EMBL accession numbers of the sequences derived from strains 18RS21, CNRCCH393, and CNRCCH265 are AAJO01000077, AM498296, and AM498295, respectively.

ACKNOWLEDGMENTS
We thank Edouard Bingen, René Courcol, Nicolas Fortineau,
Thierry Lambert, Patrice Nordmann, Marie-Cécile Ploy,
and Isabelle Podglajen for providing GBS strains from their
collections and Gregory Tirell (Provincial Laboratory for Public
Health and National Centre for Streptococcus, Canada) and Luc
Parisé (BD DiagnosticsGeneOhm) for the gifts of
GBS strains of serotype VI, VII, and VIII. We thank Franck Letourneur
and the Sequencing Platform of the Institut Cochin. We are grateful
to Alexandra Gruss for critical reading of the manuscript.
This work was supported by research funds from INSERM, CNRS, University Paris Descartes, l'Institut de Veille Sanitaire, la Fondation pour la Recherche Médicale, and the Institut Pasteur (GPH no. 9).

FOOTNOTES
* Corresponding author. Mailing address: Service de Bactériologie, Centre National de Référence des Streptocoques, Institut Cochin, INSERM567, Faculté de Médecine Paris Descartes, 27 rue du Faubourg Saint Jacques, 75014 Paris, France. Phone: 33 1 58 41 15 60. Fax: 33 1 58 41 15 48. E-mail:
claire.poyart{at}cch.aphp.fr 
Published ahead of print on 21 March 2007. 

REFERENCES
1 - Amundson, N. R., A. E. Flores, S. L. Hillier, C. J. Baker, and P. Ferrieri. 2005. DNA macrorestriction analysis of nontypeable group B streptococcal isolates: clonal evolution of nontypeable and type V isolates. J. Clin. Microbiol. 43:572-576.[Abstract/Free Full Text]
2 - Borchardt, S. M., B. Foxman, D. O. Chaffin, C. E. Rubens, P. A. Tallman, S. D. Manning, C. J. Baker, and C. F. Marrs. 2004. Comparison of DNA dot blot hybridization and Lancefield capillary precipitin methods for group B streptococcal capsular typing. J. Clin. Microbiol. 42:146-150.[Abstract/Free Full Text]
3 - Cieslewicz, M. J., D. Chaffin, G. Glusman, D. Kasper, A. Madan, S. Rodrigues, J. Fahey, M. R. Wessels, and C. E. Rubens. 2005. Structural and genetic diversity of group B streptococcus capsular polysaccharides. Infect. Immun. 73:3096-3103.[Abstract/Free Full Text]
4 - De Cueninck, B. J., T. F. Greber, T. K. Eisenstein, R. M. Swenson, and G. D. Shockman. 1983. Isolation, chemical composition, and molecular size of extracellular type II and type Ia polysaccharides of group B streptococci. Infect. Immun. 41:527-534.[Abstract/Free Full Text]
5 - Glaser, P., C. Rusniok, C. Buchrieser, F. Chevalier, L. Frangeul, T. Msadek, M. Zouine, E. Couve, L. Lalioui, C. Poyart, P. Trieu-Cuot, and F. Kunst. 2002. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol. Microbiol. 45:1499-1513.[CrossRef][Medline]
6 - Harrison, L. H., J. A. Elliott, D. M. Dwyer, J. P. Libonati, P. Ferrieri, L. Billmann, A. Schuchat, et al. 1998. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. J. Infect. Dis. 177:998-1002.[Medline]
7 - Hickman, M. E., M. A. Rench, P. Ferrieri, and C. J. Baker. 1999. Changing epidemiology of group B streptococcal colonization. Pediatrics 104:203-209.[Abstract/Free Full Text]
8 - Kong, F., S. Gowan, D. Martin, G. James, and G. L. Gilbert. 2002. Serotype identification of group B streptococci by PCR and sequencing. J. Clin. Microbiol. 40:216-226.[Abstract/Free Full Text]
9 - Kong, F., L. Ma, and G. L. Gilbert. 2005. Simultaneous detection and serotype identification of Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization. J. Med. Microbiol. 54:1133-1138.[Abstract/Free Full Text]
10 - Manning, S. D., D. W. Lacher, H. D. Davies, B. Foxman, and T. S. Whittam. 2005. DNA polymorphism and molecular subtyping of the capsular gene cluster of group B streptococcus. J. Clin. Microbiol. 43:6113-6116.[Abstract/Free Full Text]
11 - Poyart, C., M. C. Lamy, C. Boumaila, F. Fiedler, and P. Trieu-Cuot. 2001. Regulation of D-alanyl-lipoteichoic acid biosynthesis in Streptococcus agalactiae involves a novel two-component regulatory system. J. Bacteriol. 183:6324-6334.[Abstract/Free Full Text]
12 - Ramaswamy, S. V., P. Ferrieri, A. E. Flores, and L. C. Paoletti. 2006. Molecular characterization of nontypeable group B streptococcus. J. Clin. Microbiol. 44:2398-2403.[Abstract/Free Full Text]
13 - Schuchat, A. 1998. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 11:497-513.[Abstract/Free Full Text]
14 - Sellin, M., C. Olofsson, S. Hakansson, and M. Norgren. 2000. Genotyping of the capsule gene cluster (cps) in nontypeable group B streptococci reveals two major cps allelic variants of serotypes III and VII. J. Clin. Microbiol. 38:3420-3428.[Abstract/Free Full Text]
15 - Tettelin, H., V. Masignani, M. J. Cieslewicz, C. Donati, D. Medini, N. L. Ward, S. V. Angiuoli, J. Crabtree, A. L. Jones, A. S. Durkin, R. T. Deboy, T. M. Davidsen, M. Mora, M. Scarselli, I. Margarit y Ros, J. D. Peterson, C. R. Hauser, J. P. Sundaram, W. C. Nelson, R. Madupu, L. M. Brinkac, R. J. Dodson, M. J. Rosovitz, S. A. Sullivan, S. C. Daugherty, D. H. Haft, J. Selengut, M. L. Gwinn, L. Zhou, N. Zafar, H. Khouri, D. Radune, G. Dimitrov, K. Watkins, K. J. O'Connor, S. Smith, T. R. Utterback, O. White, C. E. Rubens, G. Grandi, L. C. Madoff, D. L. Kasper, J. L. Telford, M. R. Wessels, R. Rappuoli, and C. M. Fraser. 2005. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc. Natl. Acad. Sci. USA 102:13950-13955.[Abstract/Free Full Text]
16 - Tettelin, H., V. Masignani, M. J. Cieslewicz, J. A. Eisen, S. Peterson, M. R. Wessels, I. T. Paulsen, K. E. Nelson, I. Margarit, T. D. Read, L. C. Madoff, A. M. Wolf, M. J. Beanan, L. M. Brinkac, S. C. Daugherty, R. T. DeBoy, A. S. Durkin, J. F. Kolonay, R. Madupu, M. R. Lewis, D. Radune, N. B. Fedorova, D. Scanlan, H. Khouri, S. Mulligan, H. A. Carty, R. T. Cline, S. E. Van Aken, J. Gill, M. Scarselli, M. Mora, E. T. Iacobini, C. Brettoni, G. Galli, M. Mariani, F. Vegni, D. Maione, D. Rinaudo, R. Rappuoli, J. L. Telford, D. L. Kasper, G. Grandi, and C. M. Fraser. 2002. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc. Natl. Acad. Sci. USA 99:12391-12396.[Abstract/Free Full Text]
17 - Wen, L., Q. Wang, Y. Li, F. Kong, G. L. Gilbert, B. Cao, L. Wang, and L. Feng. 2006. Use of a serotype-specific DNA microarray for identification of group B streptococcus (Streptococcus agalactiae). J. Clin. Microbiol. 44:1447-1452.[Abstract/Free Full Text]
Journal of Clinical Microbiology, June 2007, p. 1985-1988, Vol. 45, No. 6
0095-1137/07/$08.00+0 doi:10.1128/JCM.00159-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Murayama, S. Y., Seki, C., Sakata, H., Sunaoshi, K., Nakayama, E., Iwata, S., Sunakawa, K., Ubukata, K., and the Invasive Streptococcal Disease Working Gro,
(2009). Capsular Type and Antibiotic Resistance in Streptococcus agalactiae Isolates from Patients, Ranging from Newborns to the Elderly, with Invasive Infections. Antimicrob. Agents Chemother.
53: 2650-2653
[Abstract]
[Full Text]
-
Brochet, M., Couve, E., Bercion, R., Sire, J.-M., Glaser, P.
(2009). Population Structure of Human Isolates of Streptococcus agalactiae from Dakar and Bangui. J. Clin. Microbiol.
47: 800-803
[Abstract]
[Full Text]
-
Evans, J. J., Bohnsack, J. F., Klesius, P. H., Whiting, A. A., Garcia, J. C., Shoemaker, C. A., Takahashi, S.
(2008). Phylogenetic relationships among Streptococcus agalactiae isolated from piscine, dolphin, bovine and human sources: a dolphin and piscine lineage associated with a fish epidemic in Kuwait is also associated with human neonatal infections in Japan. J Med Microbiol
57: 1369-1376
[Abstract]
[Full Text]
-
Martins, E. R., Melo-Cristino, J., Ramirez, M.
(2007). Reevaluating the Serotype II Capsular Locus of Streptococcus agalactiae. J. Clin. Microbiol.
45: 3384-3386
[Abstract]
[Full Text]
-
Slotved, H.-C., Kong, F., Lambertsen, L., Sauer, S., Gilbert, G. L.
(2007). Serotype IX, a Proposed New Streptococcus agalactiae Serotype. J. Clin. Microbiol.
45: 2929-2936
[Abstract]
[Full Text]
-
Gherardi, G., Imperi, M., Baldassarri, L., Pataracchia, M., Alfarone, G., Recchia, S., Orefici, G., Dicuonzo, G., Creti, R.
(2007). Molecular Epidemiology and Distribution of Serotypes, Surface Proteins, and Antibiotic Resistance among Group B Streptococci in Italy. J. Clin. Microbiol.
45: 2909-2916
[Abstract]
[Full Text]